JCB logo
Avanti Polar Lipids, Inc.
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 11 August 2003. doi:10.1083/jcb1624rr2
This Article
Right arrow Full Text (PDF, 885K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wells, W. A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Wells, W. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

© The Rockefeller University Press, 0021-9525/2003/8/532-a $5.00
The Journal of Cell Biology, Volume 162, Number 4, 532-a-532


Research Roundup

Reprogrammed by a frog



A frog oocyte germinal vesicle (center) can reprogram injected nuclei (white).

Gurdon/Elsevier

Dolly, Polly, and friends proved that somatic cells are potentially totipotent, but the reprogramming that a somatic cell nucleus must undergo during cloning remains an error-prone black box. James Byrne, John Gurdon, and colleagues (University of Cambridge, UK) have now shown that the biochemically tractable frog oocyte system can be used to model reprogramming. A modified version of their protocol might allow the isolation of elusive reprogramming factors and, eventually, the reprogramming of somatic human cells for self-transplantation of stem cells.

The Cambridge group chose frog oocytes because, unlike most eggs, oocytes are not at all active in replication but very strongly so in transcription. To see if this transcriptional activity extended to reprogramming, Gurdon microinjected the oocytes with various cells: first mouse fetal fibroblasts, then mouse adult thymic cells, and finally human lymphocytes. All cell types eventually showed robust expression of oct4, whose expression is specific to and preserves the fate of stem cells.

Transcriptional activity not associated with stem cells, such as that of ß-actin and the thymus marker thy-1, was reduced or extinguished by the transfer. But the extent of the transformation is not yet clear. "It's possible that what we are doing is turning everything into an oocyte," says Gurdon. But he believes that oct4 expression is a good sign that the cells are at least headed toward becoming stem cells.

Stem cell characteristics may develop only through sequential inductive events. But the optimists are hoping that there is a single extract that will do the entire conversion. The success of the current experiments, says Gurdon, is "one of the more compelling reasons for believing that to be true." {blacksquare}

Reference:

Byrne, J.A., et al. 2003. Curr. Biol. 13:1206–1213.[CrossRef][Medline]



William A. Wells

wellsw{at}rockefeller.edu


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Full Text (PDF, 885K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wells, W. A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Wells, W. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?


  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents